Equities research analysts expect Envision Healthcare Corp (NYSE:EVHC) to announce earnings of $1.00 per share for the current quarter, Zacks Investment Research reports. Eleven analysts have provided estimates for Envision Healthcare’s earnings. The lowest EPS estimate is $0.93 and the highest is $1.08. Envision Healthcare reported earnings per share of $0.73 during the same quarter last year, which indicates a positive year-over-year growth rate of 37%. The firm is scheduled to issue its next quarterly earnings results on Tuesday, October 30th.
According to Zacks, analysts expect that Envision Healthcare will report full year earnings of $3.63 per share for the current year, with EPS estimates ranging from $3.51 to $3.75. For the next financial year, analysts anticipate that the business will report earnings of $4.05 per share, with EPS estimates ranging from $3.78 to $4.36. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that cover Envision Healthcare.
Envision Healthcare (NYSE:EVHC) last announced its earnings results on Monday, August 6th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.87 by $0.05. Envision Healthcare had a negative net margin of 18.81% and a positive return on equity of 5.04%. The company had revenue of $2.07 billion for the quarter, compared to analyst estimates of $2.10 billion. During the same period in the prior year, the business earned $0.85 earnings per share. Envision Healthcare’s quarterly revenue was up 6.5% on a year-over-year basis.
A number of equities analysts have recently issued reports on EVHC shares. Raymond James reiterated a “market perform” rating and set a $51.00 target price on shares of Envision Healthcare in a research report on Tuesday, June 12th. SunTrust Banks lowered shares of Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, June 12th. Royal Bank of Canada lowered shares of Envision Healthcare from an “outperform” rating to a “sector perform” rating in a research report on Tuesday, June 12th. Robert W. Baird lowered shares of Envision Healthcare from an “outperform” rating to a “neutral” rating in a research report on Monday, June 11th. Finally, Canaccord Genuity lowered shares of Envision Healthcare from a “buy” rating to a “hold” rating and reduced their target price for the stock from $48.00 to $46.00 in a research report on Tuesday, June 12th. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the stock. Envision Healthcare has a consensus rating of “Hold” and a consensus target price of $41.97.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Federated Investors Inc. PA increased its stake in Envision Healthcare by 194.8% in the first quarter. Federated Investors Inc. PA now owns 2,753 shares of the company’s stock valued at $106,000 after purchasing an additional 1,819 shares in the last quarter. Rampart Investment Management Company LLC increased its stake in Envision Healthcare by 124.4% in the first quarter. Rampart Investment Management Company LLC now owns 3,362 shares of the company’s stock valued at $129,000 after purchasing an additional 1,864 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Envision Healthcare in the second quarter valued at approximately $190,000. Advisor Partners LLC bought a new stake in Envision Healthcare in the second quarter valued at approximately $206,000. Finally, Liberty Mutual Group Asset Management Inc. bought a new stake in Envision Healthcare in the second quarter valued at approximately $213,000.
Shares of EVHC stock opened at $45.30 on Thursday. Envision Healthcare has a 1 year low of $23.77 and a 1 year high of $51.19. The company has a market cap of $5.51 billion, a PE ratio of 18.27, a P/E/G ratio of 1.15 and a beta of 0.34. The company has a current ratio of 2.44, a quick ratio of 2.42 and a debt-to-equity ratio of 0.87.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.